Xeomin
These highlights do not include all the information needed to use XEOMIN safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010
ccdc3aae-6e2d-4cd0-a51c-8375bfee9458
HUMAN PRESCRIPTION DRUG LABEL
Sep 14, 2023
Merz Pharmaceuticals, LLC
DUNS: 126209282
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
incobotulinumtoxinA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
incobotulinumtoxinA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
incobotulinumtoxinA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
incobotulinumtoxinA
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
incobotulinumtoxinA
Product Details
FDA regulatory identification and product classification information